Meet option 1 and 2 or option 1 and 3: | Aged 50 to 74
/Primary lung cancer patients with pathological diagnosis and without clinical treatment or patients with pulmonary lesions highly suspicious for lung cancer and without prior treatment
|
Without diseases as listed following: | Diabetes
/Other malignant tumors except lung cancer
/Asthma
/Severe liver dysfunction
/End-stage renal disease
/Acute inflammation
|
Inform Consent Form Signature | Yes
|
- General information
- Past History
- Exhaled Breath Collection Person
- Exhaled Breath Collection Date
- Data Entry Clerk
- Data Entry Date
- Quality Control Person
- Quality Control Date
Case Number/ID Number | 364737 |
Name | LSQI |
Gender | Female
|
Age | 63 岁 |
Height | 158 cm |
Weight | 64.5 kg |
Education | Primary School
|
Own Phone Number | 18939773089 |
Relatives Phone Number |
|
Relatives Name |
|
Smoking History | No
|
Drinking History | No
|
Surgical History | Other Surgery
|
Family Cancer History | No
|
Comorbidity | No
|
Pulmonary Nodules on Past Chest CT | Yes
|
Exhaled Breath Collection Person | XTJ |
Exhaled Breath Collection Date | 2019-11-12 yyyy-mm-dd |
Data Entry Clerk | XTJ |
Data Entry Date | 2019-11-12 yyyy-mm-dd |
Quality Control Person |
|
Quality Control Date | yyyy-mm-dd |
- Tumor Marker
- FVC
- FVC%
- FEV1
- FEV1%
- FEV1/FVC
- MVV%
- DLCO SB%
- Tumor Shape on Chest CT
- Tumor Maximum Diameter on Chest CT
- Lymph Node on Chest CT
- PET-CT
Tumor Marker Increase |
FVC | 1.99 L |
FVC% | 86.8 % |
FEV1 | 1.83 L |
FEV1% | 96.1 % |
FEV1/FVC | 92.13 % |
MVV% | 60.5 % |
DLCO SB% | 114.5 % |
Tumor Shape on Chest CT | Part-Solid Nodule
|
Tumor Maximum Diameter on Chest CT | 2.1 cm |
Lymph Node on Chest CT | cN1-2(-)
|
PET-CT SUVmax | Not Done
|
Tumor Location | Right Lower Lobe
|
Surgical Approach | Three Port VATS
|
Type of Resection | Lobectomy
|
Operative Time | 175 minutes |
Intraoperative Blood Loss | 50 ml |
Intraoperative Blood Transfusion | No
|
Surgeon Name | Xiang Zhuang
|
Surgical Margin | No Residual Tumor
|
Pathological Type | Papillary Predominant Adenocarcinoma
|
Lymphovascular Invasion | No
|
Perineural Invasion | No
|
Gene Mutation | ALK(-)
/KRAS(-)
|
pT Stage, Eighth Edition | T2a
|
pN Stage, Eighth Edition | N1
|
Stations of N1 Lymph Nodes | Two Stations
|
Numbers of N1 Lymph Nodes | 5 个 |
Numbers of Metastatic N1 Lymph Nodes | 1 个 |
Stations of N2 Lymph Nodes | Three Stations
|
Numbers of N2 Lymph Nodes | 3 个 |
Numbers of Metastatic N2 Lymph Nodes | 0 个 |
Dissection of Station 7 | Yes
|
Highest N2 Status | Unknown
|
Types of Lymph Node Dissection | Selective Lymph Node Sampling
|
pM Stage, Eighth Edition | M0
|
pTNM Stage, Eighth Edition | Stage IB
|
Postoperative Complications | No
|
Non-Surgical Treatment |
Admission Date | 2019-11-05 yyyy-mm-dd |
Discharge Date | 2019-11-25 yyyy-mm-dd |
Surgery Date | 2019-11-12 yyyy-mm-dd |